Home › Therapeutic areas › Cardiovascular › Pulmonary Hypertension Associated with Interstitial Lung Disease

Pulmonary Hypertension Associated with Interstitial Lung Disease (4 companies)

Companies with an active program in Pulmonary Hypertension Associated with Interstitial Lung Disease.

Ticker Company Therapeutic areas Programs Lead stage Programs
GOSS Gossamer Bio Cardiovascular Rare 2 NDA Submitted 4
INSM Insmed CardiovascularImmunology+2 Rare 1 Approved 15
LQDA Liquidia CardiovascularImmunology+1 Rare 2 Approved 10
TECX Tectonic Therapeutic Cardiovascular Rare 1 Phase 2 3